Novel coronavirus infection sequelae evaluation method and device and computer equipment
By analyzing the characteristics of electrocardiogram signals and traditional Chinese medicine meridian detection data, and combining feature functions to evaluate the sequelae of novel coronavirus infection, the shortcomings in the existing technology to evaluate the risk of sequelae of novel coronavirus infection are solved, and high-accurate evaluation results are achieved.
Patent Information
- Application Number
- CN202411412247.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-11
- Publication Date
- 2024-11-12
AI Technical Summary
The prior art lacks effective methods to assess the sequelae of novel coronavirus infection, especially lung inflammation and heart problems.
By obtaining electrocardiogram signals and Chinese medicine meridian detection data, analyzing high-frequency QRS characteristics and Chinese medicine evaluation characteristics, and combining feature functions for evaluation, we obtain the evaluation results of the sequelae of novel coronavirus infection.
Accurate assessment of the risk of sequelae of novel coronavirus infection has been achieved, doctors provide reference for quick diagnosis and treatment suggestions, and improve the accuracy of the assessment.
Smart Images

Figure CN118942709A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of data processing technology, and in particular to a method, device, and computer equipment for evaluating sequelae of novel coronavirus infection. Background Art
[0002] The sequelae of novel coronavirus infection, also known as the long-term symptoms of novel coronavirus infection, refer to the symptoms left over after infection with the novel coronavirus, including but not limited to lung inflammation, heart problems caused by heart damage / injury (such as myocarditis, arrhythmia, myocardial infarction and / or heart failure, etc.). If the sequelae of novel coronavirus infection are not evaluated and intervened in time, it may affect the quality of life and even further affect physical fitness, leading to adverse events. Therefore, how to evaluate the sequelae of novel coronavirus infection is a problem worthy of attention.
[0003] However, there is currently a lack of technical means to effectively assess the risk of sequelae of novel coronavirus infection, mainly lung inflammation and heart problems. Summary of the invention
[0004] Based on this, it is necessary to provide a novel coronavirus infection sequelae assessment method, device, computer equipment, storage medium and computer program product that can accurately assess the risk of novel coronavirus infection sequelae in response to the above-mentioned technical problems.
[0005] A method for evaluating sequelae of novel coronavirus infection, the method comprising: Acquiring an electrocardiogram signal; the electrocardiogram signal includes an exercise electrocardiogram signal and / or a resting electrocardiogram signal; Analyze the high-frequency components of the QRS complex in the electrocardiogram signal to obtain a high-frequency QRS feature; the high-frequency QRS feature includes a motion high-frequency QRS feature and / or a resting high-frequency QRS feature; the motion high-frequency QRS feature includes the number of motion-positive leads and the number of motion-critical leads; the resting high-frequency QRS feature includes the number of resting positive leads and the number of resting critical leads; Acquire TCM meridian detection data; the TCM meridian detection data is obtained by a TCM meridian detector that collects and analyzes the bioelectricity of human acupoints according to the principles of TCM meridians; Analyze the TCM meridian detection data to obtain TCM evaluation features; The novel coronavirus infection sequelae assessment feature set is evaluated and analyzed to obtain the novel coronavirus infection sequelae assessment result; the novel coronavirus infection sequelae assessment feature set includes the high-frequency QRS feature and the traditional Chinese medicine assessment feature.
[0006] In one embodiment, the ECG signal includes a motion ECG signal; the high-frequency QRS feature includes a motion high-frequency QRS feature; the motion high-frequency QRS feature also includes a first target lead number and a second target lead number; the first target lead number is the number of chest leads indicated as positive by the lead positive indicator; the second target lead number is the number of limb leads indicated as positive by the lead positive indicator.
[0007] In one embodiment, the novel coronavirus infection sequelae assessment feature set also includes ST segment features; the method also includes: Extracting a low-frequency ECG signal from the motion ECG signal; The low-frequency electrocardiogram signal is analyzed to obtain ST segment characteristics; the ST segment characteristics include the degree of ST segment change and the duration of ST segment change of each lead.
[0008] In one embodiment, the ECG signal includes a resting ECG signal; the high-frequency QRS feature includes a resting high-frequency QRS feature; the resting high-frequency QRS feature also includes a third target lead number, a fourth target lead number, a fifth target lead number, a sixth target lead number, a seventh target lead number and a high-frequency morphological index of each lead; the third target lead number is the number of chest leads indicated as positive by the guide positive index; the fourth target lead number is the number of limb leads indicated as positive by the guide positive index; the fifth target lead number refers to the number of leads whose peak number is greater than or equal to a first quantity threshold; the sixth target lead number refers to the number of leads whose peak number is equal to a second quantity threshold; the seventh target lead number refers to the number of leads whose peak number is equal to a third quantity threshold.
[0009] In one embodiment, the analyzing the TCM meridian detection data to obtain TCM evaluation features includes: Extracting the threshold intervals corresponding to the first lung meridian value, the second lung meridian value and each preset TCM category from the TCM meridian detection data; A TCM evaluation feature is obtained according to the first lung meridian value, the second lung meridian value and the threshold intervals corresponding to the preset TCM categories.
[0010] In one embodiment, the evaluation and analysis of the novel coronavirus infection sequelae evaluation feature set to obtain the novel coronavirus infection sequelae evaluation result includes: Based on each feature in the novel coronavirus infection sequelae assessment feature set, the corresponding novel coronavirus infection sequelae assessment sub-scores are obtained respectively, and the novel coronavirus infection sequelae assessment score is obtained by summing up each novel coronavirus infection sequelae assessment sub-score.
[0011] In one embodiment, the novel coronavirus infection sequelae assessment sub-scores are obtained based on each feature in the novel coronavirus infection sequelae assessment feature set, including: Input each feature in the feature set for evaluating sequelae of novel coronavirus infection into the corresponding preconfigured feature function to obtain the corresponding sub-score for evaluating sequelae of novel coronavirus infection; The pre-configuration steps of the feature function corresponding to each feature in the feature set for evaluating sequelae of novel coronavirus infection include: Segmenting the value range corresponding to the feature to obtain one or more corresponding value ranges; According to the correlation between the feature and the risk of sequelae of novel coronavirus infection, as well as the weight of the feature, the feature sub-function corresponding to each numerical range is determined; According to each characteristic sub-function corresponding to the characteristic, a corresponding pre-configured characteristic function is obtained.
[0012] A novel coronavirus infection sequelae assessment device, comprising: An acquisition module, used for acquiring an ECG signal; the ECG signal includes an exercise ECG signal and / or a resting ECG signal; An analysis module, used for analyzing the high-frequency components of the QRS complex in the electrocardiogram signal to obtain a high-frequency QRS feature; the high-frequency QRS feature includes a motion high-frequency QRS feature and / or a resting high-frequency QRS feature; the motion high-frequency QRS feature includes the number of motion positive leads and the number of motion critical leads; the resting high-frequency QRS feature includes the number of resting positive leads and the number of resting critical leads; The acquisition module is also used to acquire TCM meridian detection data; the TCM meridian detection data is obtained by a TCM meridian detector that collects and analyzes the bioelectricity of human acupoints according to the TCM meridian theory; The analysis module is also used to analyze the TCM meridian detection data to obtain TCM evaluation features; An evaluation module is used to evaluate and analyze the novel coronavirus infection sequelae evaluation feature set to obtain a novel coronavirus infection sequelae evaluation result; the novel coronavirus infection sequelae evaluation feature set includes the high-frequency QRS feature and the traditional Chinese medicine evaluation feature.
[0013] A computer device includes a memory and a processor, wherein the memory stores a computer program, and the processor implements the steps of the method described in each method embodiment when executing the computer program.
[0014] A computer-readable storage medium stores a computer program, which, when executed by a processor, implements the steps of the method described in each method embodiment.
[0015] A computer program product includes a computer program, which implements the steps of the method described in each method embodiment when the computer program is executed by a processor.
[0016] The above-mentioned novel coronavirus infection sequelae assessment method, device, computer equipment, storage medium and computer program product obtain high-frequency QRS features including exercise high-frequency QRS features and / or resting high-frequency QRS features by acquiring and analyzing ECG signals including exercise ECG signals and / or resting ECG signals, wherein the exercise high-frequency QRS features include the number of exercise positive leads and the number of exercise critical leads, and the resting high-frequency QRS features include the number of resting positive leads and the number of resting critical leads. Furthermore, by acquiring the traditional Chinese medicine meridian detection data characterizing the overall health status of the human body obtained by collecting and analyzing the bioelectricity of human acupoints according to the principles of traditional Chinese medicine meridian science by a traditional Chinese medicine meridian detector, traditional Chinese medicine assessment features with a holistic view are extracted therefrom, and the high-frequency QRS features and the traditional Chinese medicine assessment features are combined to accurately assess the risk of novel coronavirus infection sequelae, and obtain a highly accurate novel coronavirus infection sequelae assessment result for reference by doctors, so that doctors can quickly and accurately give further diagnosis and treatment reference suggestions based on clinical symptoms and other information. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 This is a schematic diagram of a method for treating sequelae of novel coronavirus infection in one embodiment; Figure 2 This is a flow chart of a method for treating sequelae of novel coronavirus infection in another embodiment; Figure 3 This is a structural block diagram of a device for treating sequelae of novel coronavirus infection in one embodiment; Figure 4 FIG. 4 is a diagram showing the internal structure of a computer device in one embodiment. DETAILED DESCRIPTION
[0018] In order to make the purpose, technical solution and advantages of the present application more clearly understood, the present application is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application.
[0019] The novel coronavirus infection sequelae assessment method provided in this application can be applied to a terminal, a server, or an interactive system including a terminal and a server, and is implemented through the interaction between the terminal and the server, which is not specifically limited here. The terminal can be, but is not limited to, various personal computers, laptops, smart phones, tablet computers, electrocardiogram monitoring devices, and portable wearable devices, and the server can be implemented with an independent server or a server cluster consisting of multiple servers.
[0020] In one embodiment, Figure 1 As shown, a method for evaluating sequelae of novel coronavirus infection is provided. Taking application to a server as an example, the method includes the following steps: S102, acquiring an electrocardiogram signal; the electrocardiogram signal includes an exercise electrocardiogram signal and / or a resting electrocardiogram signal.
[0021] ECG signals are collected during ECG testing. ECG testing includes stress exercise ECG testing and resting ECG testing. During stress exercise ECG testing, the user is in motion to increase the user's heart load through exercise. Exercise ECG signals refer to ECG signals collected during stress exercise ECG testing. During resting ECG testing, the user is in a resting state. Resting ECG signals refer to ECG signals collected during resting ECG testing.
[0022] In one embodiment, the user's ECG signal is collected during the ECG detection process by an ECG signal collection device. The ECG signal collection device can be independent of the terminal or server, and transmit data through Bluetooth, network, electrical connection, etc., or it can be built into the terminal or server as a component, so that the server and the terminal can obtain the ECG signal from the ECG signal collection device through data interaction / transmission, and the specific method is not specifically limited.
[0023] S104, analyzing the high-frequency components of the QRS complex in the electrocardiogram signal to obtain high-frequency QRS features; the high-frequency QRS features include movement high-frequency QRS features and / or resting high-frequency QRS features; the movement high-frequency QRS features include the number of movement-positive leads and the number of movement-critical leads; the resting high-frequency QRS features include the number of resting positive leads and the number of resting critical leads.
[0024] The ECG signal includes multiple QRS complexes that reflect the changes in the left and right ventricular depolarization potentials and time. Based on the QRS complexes in the ECG signal, the corresponding high-frequency QRS features can be analyzed. The number of motion-positive leads refers to the number of leads for which the corresponding lead positive index indicates positive, which can be used to assess the risk of myocardial ischemia under load exercise, and the two are positively correlated. The number of motion-critical leads refers to the number of leads for which the corresponding lead positive index indicates critical, which can be used to assess the critical risk of myocardial ischemia under load exercise. Combining this reference feature can more accurately assess the myocardial ischemia under load exercise. The number of resting positive leads refers to the number of leads for which the corresponding lead positive index indicates positive, which can be used to characterize myocardial cell viability. The fewer the number of resting positive leads, the stronger the characterization of myocardial cell viability. The number of resting critical leads refers to the number of leads for which the corresponding lead positive index indicates critical, which can be used to assist in assessing myocardial cell viability.
[0025] Specifically, if the ECG signal includes a motion ECG signal, the high-frequency component of the QRS complex in the motion ECG signal is analyzed to obtain a motion high-frequency QRS feature. If the ECG signal includes a resting ECG signal, the high-frequency component of the QRS complex in the resting ECG signal is analyzed to obtain a resting high-frequency QRS feature. If the ECG signal includes a motion ECG signal and a resting ECG signal, a motion high-frequency QRS feature is obtained based on the QRS complex in the motion ECG signal, a resting high-frequency QRS feature is obtained based on the QRS complex in the resting ECG signal, and a corresponding high-frequency QRS feature is obtained based on the resting high-frequency QRS feature and the motion high-frequency QRS feature.
[0026] In one embodiment, if the ECG signal includes a motion ECG signal, the high-frequency QRS feature includes a motion high-frequency QRS feature, and S104 includes: analyzing the high-frequency components of the QRS wave group in the motion ECG signal to obtain a high-frequency QRS waveform curve; performing feature analysis on the high-frequency QRS waveform curve to obtain a motion high-frequency QRS feature; the motion high-frequency QRS feature includes the number of motion positive leads and the number of motion critical leads.
[0027] The exercise ECG signal includes multiple QRS wave groups that reflect the changes in the left and right ventricular depolarization potential and time. Based on the QRS wave groups in the exercise ECG signal, the corresponding high-frequency QRS waveform curve can be analyzed. The high-frequency QRS waveform curve can also be understood as a high-frequency QRS time-intensity curve, which is used to characterize the change trend of the root mean square voltage (i.e., intensity) of the high-frequency component of the user's QRS wave group over time during the entire load exercise ECG detection process, that is, it is used to reflect the energy change trend during the entire load exercise ECG detection process. The high-frequency QRS waveform curve is presented through a high-frequency QRS waveform graph. In the high-frequency QRS waveform graph, the horizontal axis is time, corresponding to the detection time of the load exercise ECG detection process, the unit is min (minutes), and the vertical axis is the root mean square voltage (RMS voltage), which can also be understood as intensity or amplitude, the unit is uV (microvolt). The exercise ECG signal includes the ECG signal corresponding to each lead, and the high-frequency QRS waveform curve corresponding to each lead can be obtained based on the exercise ECG signal.
[0028] Specifically, the motion ECG signal includes a high-frequency ECG signal and a low-frequency ECG signal. After the motion ECG signal is obtained, the corresponding high-frequency QRS waveform curve is obtained by analyzing the high-frequency components of the QRS wave group in the motion ECG signal. It can be understood that the method disclosed in the prior art can be used to obtain a high-frequency QRS waveform curve based on the motion ECG signal. For example, the effective QRS wave group in the motion ECG signal is collected, aligned and averaged, and then the ECG signal in the frequency band of 150Hz to 250Hz is filtered by a bandpass digital filter, and then the HFQRS wave group is subjected to root mean square processing, and the voltage intensity change trend is calculated to obtain a high-frequency QRS waveform curve, which will not be repeated here.
[0029] For each lead, a point with the largest root mean square voltage is selected from the high-frequency QRS waveform curve in the first time period as the first reference point, and a point with a time later than the first reference point and the smallest root mean square voltage is selected from the high-frequency QRS waveform curve in the first time period as the second reference point, and the root mean square voltage of the first reference point is subtracted from the root mean square voltage of the second reference point to obtain the absolute value of amplitude drop, and the ratio of the absolute value of amplitude drop to the root mean square voltage of the first reference point is determined as the relative value of amplitude drop, and the lead positive index corresponding to the lead is determined according to the relative value of amplitude drop and the absolute value of amplitude drop. Further, the number of leads indicated as positive by the lead positive index is screened and counted to obtain the number of motion positive leads, and the number of leads indicated as critical by the lead positive index is screened and counted to obtain the number of motion critical leads. The first time period includes a period of time before exercise, during exercise, and after exercise, the period of time before exercise is in the resting stage, the period of time during exercise includes the entire exercise stage, and the period of time after exercise is in the recovery stage, and the period of time before exercise, during exercise, and after exercise are continuous time periods. The period of time before and after exercise can be customized according to actual needs, for example, 100 seconds before exercise and 20 seconds after exercise, with no specific limitation.
[0030] In one embodiment, if the absolute value of the amplitude drop is greater than the first absolute value threshold, and the relative value of the amplitude drop is greater than the first relative value threshold, the lead positive indicator is determined to be positive. If the absolute value of the amplitude drop is greater than the first absolute value threshold, the relative value of the amplitude drop is less than or equal to the first relative value threshold and greater than the second relative value threshold, the lead positive indicator is determined to be critical. The first absolute value threshold, the first relative value threshold and the second relative value threshold can be customized according to the actual detection situation, for example, 1uV (microvolt), 50% and 45% respectively, and can also be dynamically adjusted according to the user's age and maximum heart rate, which is not specifically limited here. The second relative value threshold can also be flexibly set according to the first relative value threshold, such as the second relative value threshold is the product of the first relative value threshold and the preset percentage, and the preset percentage can be flexibly set according to needs, such as 90%, which is not specifically limited here.
[0031] In one embodiment, taking the second relative value threshold as the product of the first relative value threshold and the preset percentage as an example, if the user's age is less than the preset age and the maximum heart rate is greater than the target heart rate, the first relative value threshold is 60%; if the user's age is less than the preset age and the maximum heart rate is less than or equal to the target heart rate, the first relative value threshold is 50%; if the user's age is greater than or equal to the preset age and the maximum heart rate is greater than the target heart rate, the first relative value threshold is 50%; if the user's age is greater than or equal to the preset age and the maximum heart rate is less than or equal to the target heart rate, the first relative value threshold is 40%. The preset age can be customized, such as 50 years old. The target heart rate is determined based on the user's age and the third relative value threshold, such as target heart rate = (220-age) * third relative value threshold, "*" means multiplication, and the third relative value threshold is 80% or 85%. The maximum heart rate refers to the maximum value of the user's heart rate during the entire load exercise electrocardiogram detection process. The above is only a specific example, which can be flexibly applied according to user needs in actual applications and is not limited here.
[0032] In one embodiment, if the ECG signal includes a resting ECG signal, the high-frequency QRS feature includes a resting high-frequency QRS feature, and S104 includes: analyzing the high-frequency components of the QRS complex in the resting ECG signal to obtain a high-frequency QRS envelope curve; performing feature analysis on the high-frequency QRS envelope curve to obtain a resting high-frequency QRS feature; the resting high-frequency QRS feature includes the number of resting positive leads and the number of resting critical leads.
[0033] The resting ECG signal includes multiple QRS complexes that reflect the changes in the left and right ventricular depolarization potentials and time. Based on the QRS complexes in the resting ECG signal, the corresponding high-frequency QRS envelope curve can be analyzed. The high-frequency QRS envelope curve reflects the shape diagram obtained by averaging the high-frequency QRS complex (the high-frequency component of the QRS complex) in the resting ECG signal, and is specifically presented as a single high-frequency QRS complex envelope curve. The high-frequency QRS envelope curve is presented through a high-frequency QRS envelope diagram. In the high-frequency QRS envelope diagram, the horizontal axis is time, corresponding to the duration of the QRS complex, in ms (milliseconds), and the vertical axis is voltage, in uV (microvolts).
[0034] Specifically, the high-frequency components of the QRS complex in the resting ECG signal can be analyzed with reference to the methods disclosed in the prior art to obtain the corresponding high-frequency QRS envelope curve. The high-frequency QRS envelope curve corresponding to each lead is analyzed to obtain the total area of each amplitude reduction region on the high-frequency QRS envelope curve as the first total area, and the total area below the high-frequency QRS envelope curve as the second total area, and the ratio of the first total area to the second total area is used as the high-frequency morphological index corresponding to the lead. According to the high-frequency morphological index of each lead, the positive index of the corresponding lead is determined, and the number of leads indicated as positive by the lead positive index is screened and counted to obtain the number of resting positive leads, and the number of leads indicated as critical by the lead positive index is screened and counted to obtain the number of resting critical leads, so as to combine the number of resting positive leads with the number of resting critical leads to assess the risk of sequelae of novel coronavirus infection.
[0035] In one embodiment, if the high-frequency morphology index of the lead is greater than or equal to the first index threshold, the lead positive index corresponding to the lead is identified as positive. If the high-frequency morphology index of the lead is greater than or equal to the second index threshold and less than the first index threshold, the lead positive index corresponding to the lead is identified as critical. The first index threshold and the second index threshold can be flexibly set according to demand, such as 15% and 6% or 8% for the first index threshold. The first index threshold and the second index threshold can also be dynamically adjusted according to the age of the user, without specific limitation.
[0036] In one embodiment, if the user's age is greater than or equal to the preset age, the first index threshold is 8% and the second index threshold is 6%. If the user's age is less than the preset age, the first index threshold is 15% and the second index threshold is 8%. The preset age can be flexibly set, such as 50 years old, and is not specifically limited here.
[0037] S106, obtaining TCM meridian detection data; the TCM meridian detection data is obtained by a TCM meridian detector that collects and analyzes the bioelectricity of human acupuncture points based on the principles of TCM meridian science.
[0038] The TCM meridian detector, also known as the TCM meridian electronic detector or human meridian electronic collector, is based on the principle of TCM meridians. It collects the bioelectricity of human acupuncture points (such as the original acupuncture points of the twelve meridians) and obtains TCM meridian detection data that characterizes the overall health of the human body through quantitative analysis by computer equipment. It can be used to analyze the deficiency and excess of qi and blood, cold and heat status of the human body. The server obtains TCM meridian detection data through the TCM meridian detector.
[0039] S108, analyzing the TCM meridian detection data to obtain TCM evaluation features.
[0040] The TCM evaluation features are features with a holistic view that can be used to reflect the overall health status of the human body, including but not limited to the threshold intervals corresponding to the lung meridian value and each preset TCM category. Whether there is lung inflammation can be evaluated based on the threshold intervals corresponding to the lung meridian value and each preset TCM category. The lung meridian value includes the first lung meridian value and the second lung meridian value. The preset TCM categories include deficiency syndrome, insufficiency syndrome, balance, hyperactivity syndrome and excess syndrome. Balance is the balance of yin and yang, which is used to characterize that the human body is in a state of yin and yang balance. Deficiency syndrome, insufficiency syndrome, hyperactivity syndrome and excess syndrome all characterize that the human body is in a state of yin and yang imbalance, and are different disease manifestations caused by the internal yin and yang imbalance of the human body. The threshold intervals corresponding to each preset TCM category are determined by the bioelectric dynamics collected by the TCM meridian detector. The threshold intervals corresponding to deficiency syndrome, insufficiency syndrome, balance, hyperactivity syndrome and excess syndrome respectively constitute continuous threshold intervals in sequence, and the upper limit value of the threshold interval corresponding to the previous preset TCM category is less than the lower limit value of the threshold interval corresponding to the next preset TCM category. For example, the threshold intervals corresponding to deficiency syndrome, insufficiency syndrome, balance syndrome, hyperactivity syndrome and excess syndrome are [0, 13.3), [13.3, 16.3), [16.3, 22.3], (22.3, 25.3] and (25.3, positive infinity), respectively. This threshold interval is only used as an example.
[0041] Specifically, the threshold intervals corresponding to the lung meridian value and each preset TCM category are extracted from the TCM meridian detection data, and the TCM evaluation features are obtained according to the threshold intervals corresponding to the lung meridian value and each preset TCM category. It can be understood that the threshold intervals corresponding to the lung meridian value and each preset TCM category can be extracted by regular expressions, command lines, key field recognition, etc., or the lung meridian value and the threshold intervals corresponding to the lung meridian value and each preset TCM category can be extracted by the methods disclosed in the prior art, which are not specifically limited here.
[0042] S110, evaluating and analyzing the novel coronavirus infection sequelae evaluation feature set to obtain the novel coronavirus infection sequelae evaluation result; the novel coronavirus infection sequelae evaluation feature set includes high-frequency QRS features and traditional Chinese medicine evaluation features.
[0043] The results of the novel coronavirus infection sequelae assessment are used to characterize the risk of novel coronavirus infection sequelae. The results of the novel coronavirus infection sequelae assessment can be, but are not limited to, the novel coronavirus infection sequelae assessment score or the novel coronavirus infection sequelae assessment level. The higher the novel coronavirus infection sequelae assessment score or the higher the novel coronavirus infection sequelae assessment level, the greater the risk of novel coronavirus infection sequelae.
[0044] Specifically, the novel coronavirus infection sequelae assessment feature set is input into a preset novel coronavirus infection sequelae assessment function or a pre-trained novel coronavirus infection sequelae assessment model to obtain the corresponding novel coronavirus infection sequelae assessment result. The preset novel coronavirus infection sequelae assessment function includes the feature functions corresponding to each feature in the novel coronavirus infection sequelae assessment feature set. The novel coronavirus infection sequelae assessment model can be a single assessment model with the novel coronavirus infection sequelae assessment feature set as input features, or it can be a combined assessment model composed of feature assessment models corresponding to each feature in the novel coronavirus infection sequelae assessment feature set.
[0045] In one embodiment, S110 includes: based on each feature in the novel coronavirus infection sequelae assessment feature set, respectively obtaining corresponding novel coronavirus infection sequelae assessment sub-scores, and summing each novel coronavirus infection sequelae assessment sub-score to obtain a novel coronavirus infection sequelae assessment score.
[0046] Each feature in the feature set for evaluating sequelae of novel coronavirus infection is input into the corresponding preconfigured feature function or feature evaluation model to obtain the corresponding sub-score for evaluating sequelae of novel coronavirus infection. The sub-scores for evaluating sequelae of novel coronavirus infection are summed according to the weight of the corresponding feature to obtain the evaluation score for sequelae of novel coronavirus infection. If the sub-score for evaluating sequelae of novel coronavirus infection corresponding to a feature is greater than the weight corresponding to the feature, the sub-score for evaluating sequelae of novel coronavirus infection is reset to the weight of the corresponding feature to improve the accuracy of the evaluation.
[0047] The above-mentioned method for evaluating sequelae of novel coronavirus infection obtains and analyzes electrocardiogram signals including exercise electrocardiogram signals and / or resting electrocardiogram signals to obtain high-frequency QRS features including exercise high-frequency QRS features and / or resting high-frequency QRS features, wherein the exercise high-frequency QRS features include the number of exercise positive leads and the number of exercise critical leads, and the resting high-frequency QRS features include the number of resting positive leads and the number of resting critical leads. Furthermore, by acquiring traditional Chinese medicine meridian detection data characterizing the overall health status of the human body obtained by collecting and analyzing the bioelectricity of human acupoints according to the principles of traditional Chinese medicine meridian science by a traditional Chinese medicine meridian detector, traditional Chinese medicine evaluation features with a holistic view are extracted therefrom, and the high-frequency QRS features and the traditional Chinese medicine evaluation features are combined to accurately evaluate the risk of sequelae of novel coronavirus infection, and obtain a highly accurate evaluation result of sequelae of novel coronavirus infection for reference by doctors, so that doctors can quickly and accurately give further reference suggestions for diagnosis and treatment in combination with clinical symptoms and other information.
[0048] In one embodiment, based on each feature in the novel coronavirus infection sequelae assessment feature set, corresponding novel coronavirus infection sequelae assessment sub-scores are obtained respectively, including: inputting each feature in the novel coronavirus infection sequelae assessment feature set into the corresponding preconfigured feature function to obtain the corresponding novel coronavirus infection sequelae assessment sub-score; the preconfiguration step of the feature function corresponding to each feature in the novel coronavirus infection sequelae assessment feature set includes: segmenting the value range corresponding to the feature to obtain one or more corresponding numerical ranges; determining the feature sub-function corresponding to each corresponding numerical range according to the correlation between the feature and the novel coronavirus infection sequelae risk, and the weight of the feature; and obtaining the corresponding preconfigured feature function according to each feature sub-function corresponding to the feature.
[0049] The correlation between the feature and the risk of sequelae of novel coronavirus infection, including positive correlation and / or negative correlation. Specifically, according to the correlation between the feature and the corresponding evaluation item, the value range corresponding to the feature is divided into one or more numerical ranges, and the feature sub-function corresponding to each numerical range is determined according to the correlation between the feature and the risk of sequelae of novel coronavirus infection, and the weight of the feature, and the feature sub-functions corresponding to the feature are combined to obtain the corresponding pre-configured feature function. The evaluation item is a sub-item associated with the risk of sequelae of novel coronavirus infection, which is used to comprehensively evaluate the risk of sequelae of novel coronavirus infection, including but not limited to myocardial ischemia risk, myocardial cell vitality, and lung inflammation.
[0050] Taking the assessment item of myocardial ischemia risk as an example, the number of motion-positive leads and the number of motion-critical leads are positively correlated with myocardial ischemia risk. The more the number of motion-positive leads and the number of motion-critical leads, the higher the risk of myocardial ischemia. Therefore, the value range of the number of motion-positive leads and the number of motion-critical leads can be determined as a segmented numerical range. The value range can also be segmented into multiple numerical ranges according to the correlation between the number of motion-positive leads, the number of motion-critical leads and the degree of myocardial ischemia risk. Taking the total number of leads as 12 as an example, if the number of motion-positive leads is [1, 2], [3, 4], [5, 7], [8, 10], [11, 12], the degree of myocardial ischemia risk is represented as level one, level two, level three, level four, and level five, respectively. The higher the level, the higher the risk of myocardial ischemia and the more serious the degree.
[0051] In one embodiment, the value range corresponding to the number of motion-positive leads and the number of motion-critical leads is segmented to obtain a value range, and the expression of the characteristic function corresponding to the number of motion-positive leads and the number of motion-critical leads is as follows:
[0052] in, is the first novel coronavirus infection sequelae assessment sub-score based on the number of motor-positive leads and the number of motor-critical leads. , then Reset to , is the maximum value of the first novel coronavirus infection sequelae assessment sub-score, which is used to characterize the weight of the first novel coronavirus infection sequelae assessment sub-score in the novel coronavirus infection sequelae assessment score, that is, it is used to characterize the weight of the number of motor positive leads and the number of motor critical leads in the novel coronavirus infection sequelae assessment. and are the number of motor-positive leads and the number of motor-critical leads, and are coefficients, which can be determined based on Flexible setting, the number of positive motor leads and the number of critical motor leads are positively correlated with the risk of sequelae of novel coronavirus infection. , such as Take 60 as an example, and They are 5 and 3 respectively, and there is no specific limitation.
[0053] In one embodiment, the value range corresponding to the number of motion-positive leads and the number of motion-critical leads is segmented to obtain five value ranges, and the expression of the characteristic function corresponding to the number of motion-positive leads and the number of motion-critical leads is as follows:
[0054] in, is the first novel coronavirus infection sequelae assessment sub-score based on the number of motor-positive leads and the number of motor-critical leads. , then Reset to , is the weight corresponding to the number of motion-positive leads and the number of motion-critical leads, and The scores are based on the number of motor-positive leads and the number of motor-borderline leads, respectively.
[0055] Based on the number of motion-positive leads, the corresponding score is obtained according to the following characteristic function :
[0056] in, is the number of motor-positive leads, , , , , are coefficients, which can be determined based on Flexible settings, , such as Take 60 as an example, , , , , They are 1, 3, 5, 7, and 10 respectively, with no specific limitation.
[0057] Based on the number of motion critical leads, the corresponding score is obtained according to the following characteristic function :
[0058] in, is the number of motion critical leads, , , , , are coefficients, which can be determined based on Flexible settings, , such as Take 60 as an example, , , , , They are 0.5, 1.5, 2.5, 3.5 and 5 respectively, with no specific limitation.
[0059] In one embodiment, the expression of the feature function corresponding to the TCM evaluation feature is as follows:
[0060] in, The second novel coronavirus infection sequelae assessment sub-score based on the TCM assessment characteristics. is the maximum value of the second novel coronavirus infection sequelae assessment sub-score, which is used to characterize the weight of the second novel coronavirus infection sequelae assessment sub-score in the novel coronavirus infection sequelae assessment score, that is, it is used to characterize the weight of the traditional Chinese medicine assessment feature in the novel coronavirus infection sequelae assessment. and They are the first lung meridian value and the second lung meridian value. , , , and They are the threshold intervals corresponding to the deficiency syndrome, insufficiency syndrome, balance syndrome, hyperactivity syndrome and excess syndrome in the preset TCM categories, respectively. The threshold intervals corresponding to the preset TCM categories are extracted from the TCM meridian detection data. , , , and It is the score when the lung meridian value is in the threshold interval corresponding to the corresponding preset TCM category. It can be flexibly set according to actual needs. Flexible settings, , , , and All less than , such as Take 40 as an example, , , , and They are 28, 20, 20, 12 and 4 respectively, with no specific limitation.
[0061] It can be understood that the first lung meridian value and the second lung meridian value are only used to distinguish the left lung meridian value from the right lung meridian value, and are not used for specific limitation. For example, without departing from the scope of the present application, the left lung meridian value can be called the first lung meridian value, and the right lung meridian value can be called the second lung meridian value. Similarly, the right lung meridian value can be called the first lung meridian value, and the left lung meridian value can be called the second lung meridian value.
[0062] In one embodiment, the novel coronavirus infection sequelae assessment feature set includes the number of motion positive leads, the number of motion critical leads, the lung meridian value and the threshold interval corresponding to each preset TCM category. Based on the novel coronavirus infection sequelae assessment feature set, the expression of the novel coronavirus infection sequelae assessment function for obtaining the novel coronavirus infection sequelae assessment score can be as follows:
[0063] in, is the novel coronavirus infection sequelae assessment score obtained based on the novel coronavirus infection sequelae assessment feature set, and The meaning and expression of refer to the corresponding embodiments and will not be repeated here. and The corresponding weights can be flexibly set according to actual needs, such as 60 and 40 respectively, and no specific limitation is made here.
[0064] In the above embodiment, the risk of sequelae of novel coronavirus infection is assessed based on the number of motion-positive leads and the number of motion-critical leads obtained by analyzing the high-frequency components of the QRS complex in the exercise ECG signal, and the TCM assessment features with overall human body information, thereby improving the accuracy of the assessment.
[0065] In one embodiment, the ECG signal includes a motion ECG signal; the high-frequency QRS feature includes a motion high-frequency QRS feature; the motion high-frequency QRS feature also includes a first target lead number and a second target lead number; the first target lead number is the number of chest leads indicated as positive by the lead positive indicator; the second target lead number is the number of limb leads indicated as positive by the lead positive indicator.
[0066] Specifically, after obtaining the positive index of the corresponding lead based on the high-frequency QRS waveform curve analysis of each lead, the number of leads in the chest leads indicated as positive by the positive index is screened and counted to obtain the first target lead number, and the number of leads in the limb leads indicated as positive by the positive index is screened and counted to obtain the second target lead number, so as to also evaluate the risk of sequelae of novel coronavirus infection in combination with the first target lead number and the second target lead number.
[0067] In one embodiment, the expression of the characteristic function corresponding to the first target number of leads and the second target number of leads is as follows:
[0068] in, is the third novel coronavirus infection sequelae assessment sub-score obtained based on the first target lead number and the second target lead number. , then Reset to , is the maximum value of the third novel coronavirus infection sequelae assessment sub-score, which is used to represent the weight of the third novel coronavirus infection sequelae assessment sub-score in the novel coronavirus infection sequelae assessment score, that is, it is used to represent the weight of the first target lead number and the second target lead number in the novel coronavirus infection sequelae assessment. and are the first target lead number and the second target lead number, and They are all coefficients and can be flexibly set according to actual needs. Flexible settings, , such as Take 20 as an example, and They are 2.2 and 1.2 respectively, with no specific limitation.
[0069] In one embodiment, the novel coronavirus infection sequelae assessment feature set includes the number of motion positive leads, the number of motion critical leads, the number of first target leads, the number of second target leads, the lung meridian value and the threshold interval corresponding to each preset TCM category. Based on the novel coronavirus infection sequelae assessment feature set, the expression of the novel coronavirus infection sequelae assessment function for obtaining the novel coronavirus infection sequelae assessment score can also be as follows:
[0070] in, is the novel coronavirus infection sequelae assessment score obtained based on the novel coronavirus infection sequelae assessment feature set, , and The meaning and expression of refer to the corresponding embodiments and will not be repeated here. , and The corresponding weights can be flexibly set according to actual needs, such as 50, 30 and 20 respectively, and no specific limitation is made here.
[0071] In the above embodiment, based on the number of motion-positive leads, the number of motion-critical leads, and the TCM assessment features with overall human body information, the risk of sequelae of novel coronavirus infection is assessed by combining the number of first target leads and the number of second target leads obtained by the high-frequency components of the QRS complex in the motion ECG signal, which can further improve the accuracy of the assessment.
[0072] In one embodiment, the feature set for evaluating sequelae of novel coronavirus infection also includes ST segment features; the above-mentioned method for evaluating sequelae of novel coronavirus infection also includes: extracting low-frequency ECG signals from exercise ECG signals; analyzing the low-frequency ECG signals to obtain ST segment features; ST segment features include the degree of ST segment change and the duration of ST segment change in each lead.
[0073] ST segment changes include ST segment elevation and ST segment depression. The degree of ST segment change refers to the value of the ST segment change, that is, the value of ST segment elevation or depression, which is used to characterize the degree of ST segment elevation or depression. The duration of ST segment change refers to the duration of ST segment elevation or depression. The ST segment corresponding to each heartbeat within this duration is in an elevated or depressed state.
[0074] Specifically, the motion ECG signal includes a high-frequency ECG signal and a low-frequency ECG signal, and the low-frequency ECG signal is extracted from the motion ECG signal by analyzing the motion ECG signal. It can be understood that the method disclosed in the prior art can be used to obtain the low-frequency ECG signal based on the motion ECG signal. For example, the motion ECG signal is subjected to low-pass filtering to obtain the low-frequency ECG signal, which will not be repeated here. Further, the low-frequency ECG signal is analyzed to respectively locate and extract the corresponding ST segment features from the low-frequency ECG signal of each lead. It can be understood that the method disclosed in the prior art can be used to obtain the corresponding ST segment change degree and ST segment change duration based on the analysis of the low-frequency ECG signal of each lead.
[0075] In one embodiment, for the low-frequency ECG signal of each lead, the low-frequency ECG signal is divided into multiple signal subsets according to the time sequence and the preset step size by a window function, each signal subset includes an ECG (electrocardiogram) corresponding to at least one heartbeat, and the ECG corresponding to each heartbeat in each signal subset is aligned and averaged in turn to obtain the ECG corresponding to the signal subset (single ECG / electrocardiogram). The ECG corresponding to each signal subset is subjected to ST segment elevation or depression analysis to obtain the ST segment change degree corresponding to the signal subset (ST segment elevation degree or ST segment depression degree), and the maximum value is selected from the ST segment change degree corresponding to each signal subset as the ST segment change degree corresponding to the corresponding lead. If the ST segment elevation degree is represented by a positive number and the ST segment depression degree is represented by a negative number, the ST segment change degree with the largest absolute value is selected from the ST segment change degree corresponding to each signal subset as the ST segment change degree of the corresponding lead.
[0076] According to the time series statistics, the number of signal subsets in which the ST segment in the corresponding ECG is elevated and continuous is obtained to obtain the number of first subsets, and according to the time series statistics, the number of signal subsets in which the ST segment in the corresponding ECG is depressed and continuous is obtained to obtain the number of second subsets. The maximum value is selected from the first subset number and the second subset number as the target subset number, and the duration of ST segment change is determined according to the duration corresponding to the window function, the duration corresponding to the target subset number and the preset step length. Specifically, the duration of ST segment change = the duration corresponding to the window function + the duration corresponding to the preset step length * (target subset number - 1). It can be understood that the duration corresponding to the window function and the preset step length can be flexibly set according to actual needs. The duration of the window function is greater than or equal to the duration of the preset step length, such as 1 minute, and no specific limitation is made here.
[0077] In one embodiment, the expression of the characteristic function corresponding to the ST segment feature is as follows:
[0078] in, The fourth sub-score for the evaluation of sequelae of novel coronavirus infection based on ST segment characteristics. , then Reset to , It is the maximum value of the fourth novel coronavirus infection sequelae assessment sub-score, which is used to characterize the weight of the fourth novel coronavirus infection sequelae assessment sub-score in the novel coronavirus infection sequelae assessment score, that is, it is used to characterize the weight of ST segment characteristics in the novel coronavirus infection sequelae assessment. It is the total number of leads used to collect exercise ECG signals during the stress exercise ECG detection process. Based on The score is obtained by the degree of ST segment change in the leads. Based on The score is obtained by calculating the duration of ST segment changes in the leads.
[0079] Based on The degree of ST segment change in the leads is scored according to the following characteristic function :
[0080] in, For the The degree of ST segment change in leads, The unit of its corresponding value range is mV (millivolt). , , and Respectively The score when the ST segment change degree of each lead is within the corresponding numerical range can be flexibly set according to needs, and can also be set according to Flexible settings, If Take 15 as an example, , , and They are 0.63, 0.47, 0.32 and 0.16 respectively, and are not specifically limited here.
[0081] Based on The duration of ST segment change in the lead is scored according to the following characteristic function :
[0082] in, For the The duration of ST segment changes in leads, The corresponding value range is min (minutes), and Respectively The score when the duration of ST segment change of each lead is within the corresponding value range can be flexibly set according to needs, and can also be set according to Flexible settings, , such as Take 15 as an example, and They are 0.63 and 0.32 respectively, and are not specifically limited here.
[0083] In one embodiment, the novel coronavirus infection sequelae assessment feature set includes the number of motion-positive leads, the number of motion-critical leads, the number of first target leads, the number of second target leads, the lung meridian value, the threshold intervals corresponding to each preset TCM category, and the ST segment features. Based on the novel coronavirus infection sequelae assessment feature set, the expression of the novel coronavirus infection sequelae assessment function for obtaining the novel coronavirus infection sequelae assessment score can also be as follows:
[0084] in, is the novel coronavirus infection sequelae assessment score obtained based on the novel coronavirus infection sequelae assessment feature set, , , and The meaning and expression of refer to the corresponding embodiments and will not be repeated here. , , and The corresponding weights can be flexibly set according to actual needs, such as 45, 25, 15 and 15 respectively, and no specific limitation is made here.
[0085] In the above embodiment, based on the high-frequency QRS characteristics of exercise and the TCM evaluation characteristics, the ST segment characteristics obtained by analyzing the low-frequency components of the exercise ECG signal are also combined to evaluate the risk of sequelae of novel coronavirus infection, which can further improve the accuracy of the evaluation.
[0086] In one embodiment, the ECG signal includes a resting ECG signal; the high-frequency QRS feature includes a resting high-frequency QRS feature; and the resting high-frequency QRS feature includes a number of resting positive leads and a number of resting critical leads. If the value ranges of the number of resting positive leads and the number of resting critical leads are segmented to obtain a numerical range, the expression of the characteristic function corresponding to the number of resting positive leads and the number of resting critical leads is as follows:
[0087] in, is the fifth novel coronavirus infection sequelae assessment sub-score based on the number of resting positive leads and the number of resting critical leads. , then Reset to , It is the maximum value of the fifth novel coronavirus infection sequelae assessment sub-score, which is used to represent the weight of the fifth novel coronavirus infection sequelae assessment sub-score in the novel coronavirus infection sequelae assessment score, that is, it is used to represent the weight of the number of resting positive leads and the number of resting critical leads in the novel coronavirus infection sequelae assessment. and are the number of resting positive leads and the number of resting critical leads, and They are all coefficients and can be flexibly set according to actual needs. Flexible settings, the number of resting positive leads and the number of resting critical leads are positively correlated with the risk of sequelae of novel coronavirus infection. , such as Take 60 as an example, and They are 5 and 3 respectively, and there is no specific limitation.
[0088] In one embodiment, the value range corresponding to the number of resting positive leads and the number of resting critical leads is segmented to obtain five value ranges, and the expression of the characteristic function corresponding to the number of resting positive leads and the number of resting critical leads is as follows:
[0089] in, is the fifth novel coronavirus infection sequelae assessment sub-score based on the number of resting positive leads and the number of resting critical leads. , then Reset to , is the weight corresponding to the number of resting positive leads and the number of resting critical leads, and The scores are based on the number of resting positive leads and the number of resting borderline leads, respectively.
[0090] Based on the number of resting positive leads, the corresponding score is obtained according to the following characteristic function :
[0091] in, is the number of resting positive leads, , , , , are coefficients, which can be determined based on Flexible settings, , such as Take 60 as an example, , , , , They are 1, 3, 5, 7, and 10 respectively, with no specific limitation.
[0092] Based on the number of resting critical leads, the corresponding score is obtained according to the following characteristic function :
[0093] in, is the number of resting critical leads, , , , , are coefficients, which can be determined based on Flexible settings, , such as Take 60 as an example, , , , , They are 0.5, 1.5, 2.5, 3.5 and 5 respectively, with no specific limitation.
[0094] In one embodiment, the novel coronavirus infection sequelae assessment feature set includes the number of resting positive leads, the number of resting critical leads, the lung meridian value and the threshold interval corresponding to each preset TCM category. Based on the novel coronavirus infection sequelae assessment feature set, the expression of the novel coronavirus infection sequelae assessment function for obtaining the novel coronavirus infection sequelae assessment score can also be as follows:
[0095] in, is the novel coronavirus infection sequelae assessment score obtained based on the novel coronavirus infection sequelae assessment feature set, and The meaning and expression of refer to the corresponding embodiments and will not be repeated here. and The corresponding weights can be flexibly set according to actual needs, such as 40 and 60 respectively, and no specific limitation is made here.
[0096] In the above embodiment, the risk of sequelae of novel coronavirus infection is assessed based on the number of resting positive leads and the number of resting critical leads obtained by analyzing the high-frequency components of the QRS complex in the resting ECG signal, and the TCM assessment characteristics with overall human body information, which can improve the accuracy of the assessment.
[0097] In one embodiment, the resting high-frequency QRS feature also includes a third target lead number, a fourth target lead number, a fifth target lead number, a sixth target lead number, a seventh target lead number and a high-frequency morphology index of each lead; the third target lead number is the number of chest leads whose positive indicators indicate positive; the fourth target lead number is the number of limb leads whose positive indicators indicate positive; the fifth target lead number refers to the number of leads whose peak numbers are greater than or equal to the first quantity threshold; the sixth target lead number refers to the number of leads whose peak numbers are equal to the second quantity threshold; the seventh target lead number refers to the number of leads whose peak numbers are equal to the third quantity threshold.
[0098] The number of peaks refers to the total number of peaks on the high-frequency QRS envelope curve. The number of peaks is associated with the vitality of myocardial cells. The more peaks there are, the less vitality of myocardial cells there is. The first number threshold, the second number threshold and the third number threshold can be flexibly set according to actual needs, such as 4, 3 and 2 respectively.
[0099] Specifically, the leads include chest leads and limb leads. After the positive index of the corresponding lead is obtained based on the high-frequency QRS envelope curve analysis of each lead, the number of leads indicated as positive by the positive index in the chest lead is screened and counted to obtain the third target lead number, and the number of leads indicated as positive by the positive index in the limb lead is screened and counted to obtain the fourth target lead number, so as to also combine the first target lead number and the second target lead number to assess the risk of sequelae of novel coronavirus infection. The high-frequency QRS envelope curve of each lead is characterized to obtain the corresponding number of peaks, and the number of peaks of each lead is statistically analyzed based on each number threshold to obtain the fifth target lead number, the sixth target lead number, and the seventh target lead number. It can be understood that the number of peaks on each high-frequency QRS envelope curve can be determined in a manner disclosed in the prior art, such as determining the number of maximum values on the high-frequency QRS envelope curve as the number of peaks, which is not specifically limited here.
[0100] In one embodiment, the expression of the characteristic function corresponding to the third target number of leads and the fourth target number of leads is as follows:
[0101] in, is the sixth novel coronavirus infection sequelae assessment sub-score obtained based on the third target lead number and the fourth target lead number. , then Reset to , is the maximum value of the sixth novel coronavirus infection sequelae assessment sub-score, which is used to characterize the weight of the sixth novel coronavirus infection sequelae assessment sub-score in the novel coronavirus infection sequelae assessment score, that is, it is used to characterize the weight of the third target lead number and the fourth target lead number in the novel coronavirus infection sequelae assessment. and are the third target lead number and the fourth target lead number, and They are all coefficients and can be flexibly set according to actual needs. Flexible settings, , such as Take 10 as an example, and The values are 1 and 0.7 respectively, and there is no specific limitation.
[0102] In one embodiment, the expressions of the characteristic functions corresponding to the fifth target number of leads, the sixth target number of leads, and the seventh target number of leads are as follows:
[0103] in, is the seventh novel coronavirus infection sequelae assessment sub-score obtained based on the fifth target lead number, the sixth target lead number, and the seventh target lead number. If , then Reset to , is the maximum value of the seventh novel coronavirus infection sequelae assessment sub-score, which is used to represent the weight of the seventh novel coronavirus infection sequelae assessment sub-score in the novel coronavirus infection sequelae assessment score, that is, it is used to represent the weight of the fifth target lead number, the sixth target lead number and the seventh target lead number in the novel coronavirus infection sequelae assessment, , and They are the fifth target lead number, the sixth target lead number and the seventh target lead number, , and They are all coefficients and can be flexibly set according to actual needs. Flexible settings, , such as Take 20 as an example, , and They are 1.67, 0.84 and 0.42 respectively, without specific limitation.
[0104] In one embodiment, the expression of the characteristic function corresponding to the high-frequency morphological index is as follows:
[0105] in, is the eighth sub-score of the evaluation of sequelae of novel coronavirus infection based on the high-frequency morphological index of each lead. , then Reset to , It is the maximum value of the eighth novel coronavirus infection sequelae assessment sub-score, which is used to characterize the weight of the eighth novel coronavirus infection sequelae assessment sub-score in the novel coronavirus infection sequelae assessment score, that is, it is used to characterize the weight of the high-frequency morphological index in the novel coronavirus infection sequelae assessment. It is the total number of leads used to collect exercise ECG signals during the stress exercise ECG detection process. Based on The score obtained by the high-frequency morphology index of the leads, It can be obtained by the following expression: or
[0106] in, For the The high-frequency morphology index of the leads, , , , , , and Respectively The score when the high-frequency morphology index of the lead is in the corresponding value range can be flexibly set according to needs, and can also be set according to Flexible settings, ,and , such as Take 20 as an example, , , , , , and They are 1.67, 1.5, 1.17, 0.84, 0.5, 0.25 and 3.34 respectively, and no specific limitation is made here.
[0107] In one embodiment, the novel coronavirus infection sequelae assessment feature set includes the number of resting positive leads, the number of resting critical leads, the number of third target leads, the number of fourth target leads, the number of fifth target leads, the number of sixth target leads, the number of seventh target leads, the high-frequency morphological index of each lead, the lung meridian value and the threshold interval corresponding to each preset TCM category. Based on the novel coronavirus infection sequelae assessment feature set, the expression of the novel coronavirus infection sequelae assessment function for obtaining the novel coronavirus infection sequelae assessment score can also be as follows:
[0108] in, is the novel coronavirus infection sequelae assessment score obtained based on the novel coronavirus infection sequelae assessment feature set, , , , , The meaning and expression of refer to the corresponding embodiments and will not be repeated here. , , , , The corresponding weights can be flexibly set according to actual needs, such as 20, 30, 10, 20 and 20 respectively, and no specific limitation is made here.
[0109] In the above embodiment, based on the number of resting positive leads, the number of resting critical leads and the TCM evaluation characteristics, the risk of sequelae of novel coronavirus infection is assessed in combination with the number of third target leads, the number of fourth target leads, the number of fifth target leads, the number of sixth target leads, the number of seventh target leads and the high-frequency morphological index of each lead, which can further improve the accuracy of the assessment.
[0110] In one embodiment, the novel coronavirus infection sequelae assessment feature set includes high-frequency QRS features and traditional Chinese medicine assessment features, and the high-frequency QRS features include motion high-frequency QRS features and resting high-frequency QRS features. With reference to one or more embodiments in this application, the motion high-frequency QRS feature includes a corresponding plurality of features, and similarly, the resting high-frequency QRS feature includes a corresponding plurality of features. Thus, with reference to the various embodiments in this application, the motion high-frequency QRS feature, the resting high-frequency QRS feature, and the traditional Chinese medicine assessment feature have a variety of combinations, that is, each feature in the novel coronavirus infection sequelae assessment feature set has a variety of combinations.
[0111] Taking the example that the motion high-frequency QRS features include the number of motion positive leads, the number of motion critical leads, the number of first target leads and the number of second target leads, and the resting high-frequency QRS features include the number of resting positive leads, the number of resting critical leads, the number of third target leads, the number of fourth target leads, the number of fifth target leads, the number of sixth target leads, the number of seventh target leads and the high-frequency morphological index of each lead, the expression of the novel coronavirus infection sequelae evaluation function for obtaining the novel coronavirus infection sequelae evaluation score based on the novel coronavirus infection sequelae evaluation feature set can also be as follows:
[0112] in, is the novel coronavirus infection sequelae assessment score obtained based on the novel coronavirus infection sequelae assessment feature set, , , , , , , The meaning and expression of refer to the corresponding embodiments and will not be repeated here. , , , , , , The corresponding weights can be flexibly set according to actual needs, such as 25, 13, 9, 22, 9, 11 and 11 respectively, and no specific limitation is made here.
[0113] If the feature set for evaluating sequelae of novel coronavirus infection also includes ST segment features, then referring to the various embodiments in this application, there are multiple combinations of high-frequency QRS features of movement, high-frequency QRS features of rest, TCM evaluation features and ST segment features, which means that each feature in the feature set for evaluating sequelae of novel coronavirus infection has multiple combinations. Based on the above examples, if the feature set for evaluating sequelae of novel coronavirus infection also includes ST segment features, the expression of the evaluation function for sequelae of novel coronavirus infection can also be as follows:
[0114] in, is the novel coronavirus infection sequelae assessment score obtained based on the novel coronavirus infection sequelae assessment feature set, , , , , , , , The meaning and expression of refer to the corresponding embodiments and will not be repeated here. , , , , , , , The corresponding weights can be flexibly set according to actual needs, such as 24, 12, 8, 8, 20, 8, 10 and 10 respectively, and no specific limitation is made here.
[0115] It is worth noting that this embodiment only provides examples for some combinations and is not intended to be a specific limitation. The expressions of the novel coronavirus infection sequelae evaluation function and the weights of each feature corresponding to other combinations are not listed here one by one. The novel coronavirus infection sequelae evaluation function includes the feature functions corresponding to each feature in the novel coronavirus infection sequelae evaluation feature set. When the weights of each feature in the novel coronavirus infection sequelae evaluation feature set change, it is necessary to dynamically adjust the coefficients and / or scores in the feature functions corresponding to each feature to The corresponding weight Take 24 as an example, then The weight in the corresponding feature function and Dynamically adjusted to 2 and 1.2 respectively.
[0116] In one or more embodiments of the present application, the coefficients or scores of the corresponding features in each feature function when they are in each numerical range, as well as the weights of each feature in the risk assessment of sequelae of novel coronavirus infection, can be determined by the terminal and / or server based on the automatic learning of the labeled sample set, or can be manually set or modified in the function pre-configuration stage, or can be determined by a combination of automatic learning and manual setting or modification. In one embodiment, the highest sub-score obtained based on the feature function corresponding to the feature is greater than or equal to the weight corresponding to the feature, and less than or equal to the product of the weight corresponding to the feature and the weight coefficient. The weight coefficient can be flexibly set according to actual needs, such as 10%, which is not specifically limited here.
[0117] In one embodiment, when evaluating the risk of sequelae of novel coronavirus infection by referring to the sequelae assessment score of novel coronavirus infection, the corresponding reference standard (such as score threshold, score range, etc.) needs to be dynamically adjusted according to the feature function corresponding to each feature.
[0118] In one embodiment, in one or more embodiments of the present application, the sum of the weights corresponding to the features in the novel coronavirus infection sequelae assessment feature set is 100 as an example, that is, the upper limit value (full score) of the novel coronavirus infection sequelae assessment score is 100 as an example. It can be understood that the sum of the weights corresponding to the features in the novel coronavirus infection sequelae assessment feature set may not be limited to 100, that is, the upper limit value (full score) of the novel coronavirus infection sequelae assessment score may not be limited to 100. If the upper limit value (full score) of the novel coronavirus infection sequelae assessment score is not limited to 100, when evaluating the risk of novel coronavirus infection sequelae with reference to the novel coronavirus infection sequelae assessment score, the corresponding reference standard (such as score threshold, score range, etc.) needs to be dynamically adjusted according to the upper limit value.
[0119] In one embodiment, if the novel coronavirus infection sequelae assessment feature set is used as an input feature to input into a pre-trained novel coronavirus infection sequelae assessment model for prediction, and the novel coronavirus infection sequelae assessment result is obtained, then the features in the novel coronavirus infection sequelae assessment feature set used as input features during prediction are the same as the features in the novel coronavirus infection sequelae assessment feature set used as input features during model training. Thus, corresponding novel coronavirus infection sequelae assessment models can be trained for one or more combinations of features in the novel coronavirus infection sequelae assessment feature set, so that corresponding novel coronavirus infection sequelae assessment models can be selected according to actual conditions during prediction to perform novel coronavirus infection sequelae risk assessment.
[0120] It is worth noting that the meanings, values, value ranges, etc. of the expressions and their parameters in one or more embodiments of the present application are only examples and are not intended to be specific limitations. They can be flexibly set according to actual needs.
[0121] In one embodiment, S108 includes: extracting the threshold intervals corresponding to the first lung meridian value, the second lung meridian value and each preset TCM category from the TCM meridian detection data; and obtaining TCM evaluation features according to the threshold intervals corresponding to the first lung meridian value, the second lung meridian value and each preset TCM category.
[0122] Specifically, after obtaining the TCM meridian detection data through the TCM meridian detector, a regular expression is pre-constructed for the TCM evaluation features to be extracted, and the regular expression is matched with the TCM meridian detection data to find and extract the corresponding TCM evaluation features from the TCM meridian detection data. Alternatively, a command line is pre-constructed for the TCM evaluation features to be extracted, the TCM meridian detection data is searched based on the command line, and the TCM evaluation features are extracted based on the search results. Alternatively, key fields are identified for the TCM meridian detection data, and the corresponding key field values are extracted based on the identified key fields to obtain the TCM evaluation features. It can be understood that the TCM evaluation features can also be extracted from the TCM meridian detection data in the manner disclosed in the prior art.
[0123] For example, taking the TCM evaluation feature including the lung meridian value as an example, assuming that the lung meridian value in the TCM meridian detection data is "lung meridian = numerical value / number representing the lung meridian value", if the regular expression method is used, the pre-constructed regular expression such as "lung meridian = \\d+\\.\\d+" can extract the numerical value corresponding to the lung meridian value from the TCM meridian detection data based on the regular expression. If the command line method is used, "lung meridian = numerical value / number representing the lung meridian value" can be searched from the TCM meridian detection data based on the command line to obtain the numerical value corresponding to the lung meridian value. If the field recognition method is used, the key field "lung meridian" is identified from the TCM meridian detection data, and the key field value corresponding to the key field is used as the numerical value corresponding to the extracted lung meridian value, so as to obtain the lung meridian value, a TCM evaluation feature, based on the lung meridian value and the corresponding numerical value. For the field recognition method, if the identified key field does not have a corresponding key field value, continue to search for the key field with the corresponding key field value to extract the corresponding key field value.
[0124] It can be understood that other TCM evaluation features can be processed in a similar manner, such as extracting the threshold intervals corresponding to each preset TCM category from the TCM meridian detection data in a similar manner as described above. Of course, the processing method is not limited to the above example and will not be repeated here.
[0125] In the above embodiment, the TCM evaluation features are obtained by extracting the first lung meridian value, the second lung meridian value and the threshold intervals corresponding to each preset TCM category from the TCM meridian detection data, so that the risk of sequelae of novel coronavirus infection can be more accurately assessed by combining the TCM evaluation features.
[0126] In one embodiment, Figure 2 As shown, a method for evaluating sequelae of novel coronavirus infection is provided, and the method specifically comprises the following steps: S202, acquiring an electrocardiogram signal; the electrocardiogram signal includes an exercise electrocardiogram signal and a resting electrocardiogram signal.
[0127] S204, analyzing the high-frequency components of the QRS wave group in the exercise electrocardiogram signal to obtain a high-frequency QRS waveform curve.
[0128] S206, performing feature analysis on the high-frequency QRS waveform curve to obtain a motion high-frequency QRS feature; the motion high-frequency QRS feature includes the number of motion-positive leads, the number of motion-critical leads, the number of first target leads and the number of second target leads; the number of first target leads is the number of chest leads indicated as positive by the lead positive index; the number of second target leads is the number of limb leads indicated as positive by the lead positive index.
[0129] S208, extracting a low-frequency ECG signal from the motion ECG signal.
[0130] S210, analyzing the low-frequency ECG signal to obtain ST segment features; the ST segment features include the degree of ST segment change and the duration of ST segment change in each lead.
[0131] S212, analyzing the high-frequency components of the QRS complex in the resting electrocardiogram signal to obtain a high-frequency QRS envelope curve.
[0132] S214, perform feature analysis on the high-frequency QRS envelope curve to obtain resting high-frequency QRS features; the resting high-frequency QRS features include the number of resting positive leads, the number of resting critical leads, the number of third target leads, the number of fourth target leads, the number of fifth target leads, the number of sixth target leads, the number of seventh target leads and the high-frequency morphological index of each lead; the number of third target leads is the number of chest leads indicated as positive by the guide link positive index; the number of fourth target leads is the number of limb leads indicated as positive by the guide link positive index; the number of fifth target leads refers to the number of leads whose number of peaks is greater than or equal to the first quantity threshold; the number of sixth target leads refers to the number of leads whose number of peaks is equal to the second quantity threshold; the number of seventh target leads refers to the number of leads whose number of peaks is equal to the third quantity threshold.
[0133] S216, obtaining TCM meridian detection data; the TCM meridian detection data is obtained by a TCM meridian detector that collects and analyzes the bioelectricity of human acupuncture points based on the principles of TCM meridian science.
[0134] S218, extracting the first lung meridian value, the second lung meridian value and the threshold intervals corresponding to each preset TCM category from the TCM meridian detection data.
[0135] S220, obtaining a TCM evaluation feature according to the first lung meridian value, the second lung meridian value and the threshold intervals corresponding to each preset TCM category.
[0136] S222, input each feature in the novel coronavirus infection sequelae assessment feature set into the corresponding preconfigured feature function to obtain the corresponding novel coronavirus infection sequelae assessment sub-score, and sum up the novel coronavirus infection sequelae assessment sub-scores to obtain the novel coronavirus infection sequelae assessment score; the novel coronavirus infection sequelae assessment feature set includes high-frequency QRS features, traditional Chinese medicine assessment features and ST segment features; the high-frequency QRS features include motion high-frequency QRS features and / or resting high-frequency QRS features.
[0137] In the above embodiment, the exercise ECG signal under the exercise load state is obtained and analyzed to obtain the exercise high-frequency QRS characteristics and ST segment characteristics, the resting ECG signal under the resting load state is obtained and analyzed to obtain the resting high-frequency QRS characteristics, and the TCM meridian detection data is obtained and analyzed to obtain the TCM evaluation characteristics with a holistic view, so as to combine the characteristics of these multiple dimensions to evaluate and analyze the risk of sequelae of novel coronavirus infection, which can improve the accuracy of the evaluation and obtain a more accurate evaluation result of sequelae of novel coronavirus infection for reference by doctors.
[0138] It should be understood that although Figure 1 and Figure 2 The steps in the flowchart are shown in sequence as indicated by the arrows, but these steps are not necessarily executed in the order indicated by the arrows. Unless otherwise specified in this document, there is no strict order restriction for the execution of these steps, and these steps can be executed in other orders. Moreover, Figure 1 and Figure 2 At least part of the steps may include multiple steps or multiple stages. These steps or stages are not necessarily performed at the same time, but can be performed at different times. The execution order of these steps or stages is not necessarily sequential, but can be performed in turn or alternately with other steps or at least part of the steps or stages in other steps.
[0139] In one embodiment, Figure 3 As shown, a novel coronavirus infection sequelae evaluation device 300 is provided, comprising: an acquisition module 301, an analysis module 302 and an evaluation module 303, wherein: The acquisition module 301 is used to acquire an ECG signal; the ECG signal includes an exercise ECG signal and / or a resting ECG signal; The analysis module 302 is used to analyze the high-frequency components of the QRS complex in the electrocardiogram signal to obtain high-frequency QRS features; the high-frequency QRS features include motion high-frequency QRS features and / or resting high-frequency QRS features; the motion high-frequency QRS features include the number of motion positive leads and the number of motion critical leads; the resting high-frequency QRS features include the number of resting positive leads and the number of resting critical leads; The acquisition module 301 is also used to acquire TCM meridian detection data; the TCM meridian detection data is obtained by a TCM meridian detector that collects and analyzes the bioelectricity of human acupoints according to the TCM meridian theory; The analysis module 302 is also used to analyze the TCM meridian detection data to obtain TCM evaluation features; The evaluation module 303 is used to evaluate and analyze the novel coronavirus infection sequelae evaluation feature set to obtain the novel coronavirus infection sequelae evaluation result; the novel coronavirus infection sequelae evaluation feature set includes high-frequency QRS features and traditional Chinese medicine evaluation features.
[0140] In one embodiment, the ECG signal includes a motion ECG signal; the high-frequency QRS feature includes a motion high-frequency QRS feature; the motion high-frequency QRS feature also includes a first target lead number and a second target lead number; the first target lead number is the number of chest leads indicated as positive by the lead positive indicator; the second target lead number is the number of limb leads indicated as positive by the lead positive indicator.
[0141] In one embodiment, the feature set for evaluating sequelae of novel coronavirus infection also includes ST segment features. The analysis module 302 is also used to extract low-frequency ECG signals from exercise ECG signals; analyze the low-frequency ECG signals to obtain ST segment features; ST segment features include the degree of ST segment change and the duration of ST segment change in each lead.
[0142] In one embodiment, the ECG signal includes a resting ECG signal; the high-frequency QRS feature includes a resting high-frequency QRS feature; the resting high-frequency QRS feature also includes a third target lead number, a fourth target lead number, a fifth target lead number, a sixth target lead number, a seventh target lead number and a high-frequency morphological index of each lead; the third target lead number is the number of chest leads indicated as positive by the guide positive index; the fourth target lead number is the number of limb leads indicated as positive by the guide positive index; the fifth target lead number refers to the number of leads whose peak number is greater than or equal to the first quantity threshold; the sixth target lead number refers to the number of leads whose peak number is equal to the second quantity threshold; the seventh target lead number refers to the number of leads whose peak number is equal to the third quantity threshold.
[0143] In one embodiment, the analysis module 302 is also used to extract the threshold intervals corresponding to the first lung meridian value, the second lung meridian value and each preset TCM category from the TCM meridian detection data; and obtain the TCM evaluation features according to the threshold intervals corresponding to the first lung meridian value, the second lung meridian value and each preset TCM category.
[0144] In one embodiment, the evaluation module 303 is also used to obtain corresponding novel coronavirus infection sequelae evaluation sub-scores based on each feature in the novel coronavirus infection sequelae evaluation feature set, and sum up each novel coronavirus infection sequelae evaluation sub-score to obtain the novel coronavirus infection sequelae evaluation score.
[0145] In one embodiment, the evaluation module 303 is also used to input each feature in the novel coronavirus infection sequelae evaluation feature set into the corresponding preconfigured feature function to obtain the corresponding novel coronavirus infection sequelae evaluation sub-score; segment the value range corresponding to the feature to obtain one or more corresponding numerical ranges; determine the feature sub-function corresponding to each corresponding numerical range according to the correlation between the feature and the novel coronavirus infection sequelae risk, and the weight of the feature; and obtain the corresponding preconfigured feature function according to each feature sub-function corresponding to the feature.
[0146] For the specific definition of the new coronavirus infection sequelae evaluation device, please refer to the definition of the new coronavirus infection sequelae evaluation method above, which will not be repeated here. Each module in the above-mentioned new coronavirus infection sequelae evaluation device can be implemented in whole or in part by software, hardware and a combination thereof. The above-mentioned modules can be embedded in or independent of the processor in the computer device in the form of hardware, or can be stored in the memory of the computer device in the form of software, so that the processor can call and execute the operations corresponding to the above modules.
[0147] In one embodiment, a computer device is provided. The computer device may be a server, and its internal structure diagram may be as follows: Figure 4 As shown. The computer device includes a processor, a memory and a network interface connected through a system bus. Among them, the processor of the computer device is used to provide computing and control capabilities. The memory of the computer device includes a non-volatile storage medium and an internal memory. The non-volatile storage medium stores an operating system, a computer program and a database. The internal memory provides an environment for the operation of the operating system and the computer program in the non-volatile storage medium. The database of the computer device is used to store electrocardiogram signals and traditional Chinese medicine meridian detection data. The network interface of the computer device is used to communicate with an external terminal through a network connection. When the computer program is executed by the processor, a method for evaluating sequelae of novel coronavirus infection is implemented.
[0148] Those skilled in the art will understand that Figure 4 The structure shown in the figure is only a block diagram of a part of the structure related to the solution of the present application, and does not constitute a limitation on the computer device to which the solution of the present application is applied. The specific computer device may include more or fewer components than those shown in the figure, or combine certain components, or have a different arrangement of components.
[0149] In one embodiment, a computer device is further provided, including a memory and a processor, wherein a computer program is stored in the memory, and the processor implements the steps in the above method embodiments when executing the computer program.
[0150] In one embodiment, a computer-readable storage medium is provided, on which a computer program is stored. When the computer program is executed by a processor, the steps in the above-mentioned method embodiments are implemented.
[0151] In one embodiment, a computer program product is provided, including a computer program, which implements the steps in the above method embodiments when executed by a processor.
[0152] Those skilled in the art can understand that all or part of the processes in the above-mentioned embodiment methods can be completed by instructing the relevant hardware through a computer program, and the computer program can be stored in a non-volatile computer-readable storage medium. When the computer program is executed, it can include the processes of the embodiments of the above-mentioned methods. Among them, any reference to memory, storage, database or other media used in the embodiments provided in this application may include at least one of non-volatile and volatile memory. Non-volatile memory may include read-only memory (ROM), tape, floppy disk, flash memory or optical memory, etc. Volatile memory may include random access memory (RAM) or external cache memory. As an illustration and not limitation, RAM can be in various forms, such as static random access memory (SRAM) or dynamic random access memory (DRAM).
[0153] The technical features of the above embodiments may be combined arbitrarily. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0154] The above embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent of the present application shall be subject to the attached claims.
Claims
1. A method for evaluating sequelae of novel coronavirus infection, It is characterized in that The method comprises: Acquiring an electrocardiogram signal; the electrocardiogram signal includes an exercise electrocardiogram signal and / or a resting electrocardiogram signal; Analyze the high-frequency components of the QRS complex in the electrocardiogram signal to obtain a high-frequency QRS feature; the high-frequency QRS feature includes a motion high-frequency QRS feature and / or a resting high-frequency QRS feature; the motion high-frequency QRS feature includes the number of motion-positive leads and the number of motion-critical leads; the resting high-frequency QRS feature includes the number of resting positive leads and the number of resting critical leads; Acquire TCM meridian detection data; the TCM meridian detection data is obtained by a TCM meridian detector that collects and analyzes the bioelectricity of human acupoints according to the principles of TCM meridians; Analyze the TCM meridian detection data to obtain TCM evaluation features; An evaluation and analysis is performed on the novel coronavirus infection sequelae evaluation feature set to obtain a novel coronavirus infection sequelae evaluation result; the novel coronavirus infection sequelae evaluation feature set includes the high-frequency QRS feature and the traditional Chinese medicine evaluation feature.
2. The method according to claim 1, It is characterized in that The ECG signal includes a motion ECG signal; the high-frequency QRS feature includes a motion high-frequency QRS feature; the motion high-frequency QRS feature also includes a first target lead number and a second target lead number; the first target lead number is the number of chest leads indicated as positive by the lead positive indicator; the second target lead number is the number of limb leads indicated as positive by the lead positive indicator.
3. The method according to claim 2, It is characterized in that The novel coronavirus infection sequelae assessment feature set also includes ST segment features; the method also includes: Extracting a low-frequency ECG signal from the motion ECG signal; The low-frequency electrocardiogram signal is analyzed to obtain ST segment characteristics; the ST segment characteristics include the degree of ST segment change and the duration of ST segment change of each lead.
4. The method according to claim 1, It is characterized in that The ECG signal includes a resting ECG signal; the high-frequency QRS feature includes a resting high-frequency QRS feature; the resting high-frequency QRS feature also includes a third target lead number, a fourth target lead number, a fifth target lead number, a sixth target lead number, a seventh target lead number and a high-frequency morphological index of each lead; the third target lead number is the number of chest leads whose positive indicators indicate positive; the fourth target lead number is the number of limb leads whose positive indicators indicate positive; the fifth target lead number refers to the number of leads whose peak numbers are greater than or equal to a first quantity threshold; the sixth target lead number refers to the number of leads whose peak numbers are equal to a second quantity threshold; the seventh target lead number refers to the number of leads whose peak numbers are equal to a third quantity threshold.
5. The method according to claim 1, It is characterized in that The analyzing the TCM meridian detection data to obtain TCM evaluation features includes: Extracting the threshold intervals corresponding to the first lung meridian value, the second lung meridian value and each preset TCM category from the TCM meridian detection data; A TCM evaluation feature is obtained according to the first lung meridian value, the second lung meridian value and the threshold intervals corresponding to the preset TCM categories.
6. The method according to any one of claims 1 to 5, It is characterized in that The novel coronavirus infection sequelae assessment feature set is evaluated and analyzed to obtain the novel coronavirus infection sequelae assessment results, including: Based on each feature in the novel coronavirus infection sequelae assessment feature set, the corresponding novel coronavirus infection sequelae assessment sub-scores are obtained respectively, and the novel coronavirus infection sequelae assessment score is obtained by summing up each novel coronavirus infection sequelae assessment sub-score.
7. The method according to claim 6, It is characterized in that Based on each feature in the novel coronavirus infection sequelae assessment feature set, the corresponding novel coronavirus infection sequelae assessment sub-scores are obtained, including: Input each feature in the feature set for evaluating sequelae of novel coronavirus infection into the corresponding preconfigured feature function to obtain the corresponding sub-score for evaluating sequelae of novel coronavirus infection; The pre-configuration steps of the feature function corresponding to each feature in the feature set for evaluating sequelae of novel coronavirus infection include: Segmenting the value range corresponding to the feature to obtain one or more corresponding value ranges; According to the correlation between the feature and the risk of sequelae of novel coronavirus infection, as well as the weight of the feature, the feature sub-function corresponding to each numerical range is determined; According to each characteristic sub-function corresponding to the characteristic, a corresponding pre-configured characteristic function is obtained.
8. A device for evaluating sequelae of novel coronavirus infection, It is characterized in that The device comprises: An acquisition module, used for acquiring an ECG signal; the ECG signal includes an exercise ECG signal and / or a resting ECG signal; An analysis module, used for analyzing the high-frequency components of the QRS complex in the electrocardiogram signal to obtain a high-frequency QRS feature; the high-frequency QRS feature includes a motion high-frequency QRS feature and / or a resting high-frequency QRS feature; the motion high-frequency QRS feature includes the number of motion positive leads and the number of motion critical leads; the resting high-frequency QRS feature includes the number of resting positive leads and the number of resting critical leads; The acquisition module is also used to acquire TCM meridian detection data; the TCM meridian detection data is obtained by a TCM meridian detector that collects and analyzes the bioelectricity of human acupoints according to the TCM meridian theory; The analysis module is also used to analyze the TCM meridian detection data to obtain TCM evaluation features; An evaluation module is used to evaluate and analyze the novel coronavirus infection sequelae evaluation feature set to obtain a novel coronavirus infection sequelae evaluation result; the novel coronavirus infection sequelae evaluation feature set includes the high-frequency QRS feature and the traditional Chinese medicine evaluation feature.
9. A computer device comprising a memory and a processor, wherein the memory stores a computer program. It is characterized in that When the processor executes the computer program, the steps of the method according to any one of claims 1 to 7 are implemented.
10. A computer-readable storage medium having a computer program stored thereon, It is characterized in that When the computer program is executed by a processor, the steps of the method according to any one of claims 1 to 7 are implemented.
11. A computer program product comprising a computer program, It is characterized in that When the computer program is executed by a processor, the steps of the method according to any one of claims 1 to 7 are implemented.
Citation Information
Patent Citations
Coronary heart disease risk assessment method, coronary heart disease risk assessment device, sudden cardiac death risk assessment method and sudden cardiac death risk assessment system
CN115581465A
Heart risk assessment method and device, computer equipment and storage medium
CN116616790A
Cited By
Coronary artery lesion risk prediction method, device and system and storage medium
CN121421484A
